Back to search: Senior scientist / Hong Kong

Senior scientist

Hong Kong
Innorna

Published on www.allthetopbananas.com 18 Mar 2025

On-site Full Time 3 year or above Mid-Senior level Skills: Biotechnology Responsibilities: Design and develop bioinformatics analysis processes for sequence optimization. Participate in experimental design and data analysis for research projects. Work closely with the R&D team to identify problems that bioinformatics can solve and provide technical support. Participate in the management and maintenance of the company's database and bioinformatics platform. Provide bioinformatics technical support to internal and external partners. Conduct bioinformatics-related research and apply it to the company's business. Ensure the quality and accuracy of analysis results. Write and publish relevant research results and reports. Conduct research on new technologies and make suggestions for optimization. Requirements: Ph D degree in Bioinformatics, Computational Biology, or related fields. Strong knowledge and practical experience in bioinformatics, computational biology. Proficiency in bioinformatics analysis software and programming languages such as R and Python. Strong experience in analyzing and interpreting bioinformatics data. Ability to work in a team and excellent communication skills, with a sense of teamwork and service. Possess strong independent problem-solving and critical thinking skills. Diligent, passionate about research, meticulous, patient and responsible. Machine learning skills are a plus. Additional Information Job Level Mid-Senior level Publish Date11/02/2025 Job Ref. No.022025 TPJob Function Biotechnology Research / Analysis Company Overview Founded in 2019, Innorna is committed to developing the world's leading LNP delivery technology platform and innovative RNA therapies to address unmet clinical needs. Innorna has established a Diversity-Oriented LNP Library (DOLL) containing more than 5,000 ionizable lipids, which can be applied to the development of a variety of innovative therapies, including m RNA vaccines and drugs, gene editing therapies, and cell therapies. Based on its proprietary m RNA and LNP technology platforms, Innorna has deployed multiple internal R&D pipelines in the fields of infectious diseases vaccines, rare diseases, and tumor immunology. Over the past five years, Innorna has gained a lot of attention from the investment and biotech community and has received dozens of titles and awards, including MIT Technology Review's Global 50 Smart Companies and Fortune China's Start-ups with the Most Social Impact. #J-18808-Ljbffr
View all